Australia markets close in 5 hours 11 minutes

Protara Therapeutics, Inc. (TARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.8300-0.0400 (-1.39%)
At close: 04:00PM EDT
2.8100 -0.02 (-0.71%)
After hours: 05:04PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 59.09M
Enterprise value 9.10M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.01
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.20

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-11.96%
S&P500 52-week change 325.38%
52-week high 35.2400
52-week low 31.0400
50-day moving average 33.5497
200-day moving average 32.4142

Share statistics

Avg vol (3-month) 3289.44k
Avg vol (10-day) 3269.88k
Shares outstanding 520.59M
Implied shares outstanding 620.59M
Float 814.35M
% held by insiders 16.18%
% held by institutions 141.68%
Shares short (15 Apr 2024) 4398.34k
Short ratio (15 Apr 2024) 40.76
Short % of float (15 Apr 2024) 45.29%
Short % of shares outstanding (15 Apr 2024) 43.48%
Shares short (prior month 15 Mar 2024) 461.44k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 310 Jan 2020
Ex-dividend date 4N/A
Last split factor 21:40
Last split date 310 Jan 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-32.75%
Return on equity (ttm)-55.45%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -45.38M
Net income avi to common (ttm)-42.47M
Diluted EPS (ttm)-3.7400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)55.22M
Total cash per share (mrq)2.68
Total debt (mrq)5.23M
Total debt/equity (mrq)8.95%
Current ratio (mrq)10.53
Book value per share (mrq)5.11

Cash flow statement

Operating cash flow (ttm)-35.05M
Levered free cash flow (ttm)-17.84M